Complete Up To Date Information about Spectramast™ DC Sterile Suspension.
NADA Number: 141-239 | |
| Proprietary Name |
Spectramast™ DC Sterile Suspension |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Ceftiofur Hydrochloride |
| Species |
Cattle, dairy, dry cows |
| Routes of Administration |
Intramammary |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
| Patent Number |
4902683 |
| Exclusivity |
For the treatment of subclinical mastitis in dry dairy cattle at the time of dry off associated with Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus uberis . |
| Withdrawal Time |
Milk: zero days (following completion of a 30-day dry off period).
Cattle: 16 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
526.313 Ceftiofur Specifications Each single-use, 10-milliliter syringe of ceftiofur hydrochloride suspension contains or 500 milligrams (mg)ceftiofur equivalents. Conditions of use: Dairy cattle (at dry off) Amount: Infuse 500 mg per affected quarter at the time of dry off. Indications: For the treatment of subclinical mastitis in dairy cattle at the time of dry off associated with Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus uberis. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Milk taken from cows completing a 30-day dry off period may be used for food with no milk discard due to ceftiofur residues. Following intramammary infusion, a 16-day pre-slaughter withdrawal period is required for treated cows. Following label use, no pre-slaughter withdrawal period is required for neonatal calves from treated cows regardless of colostrum consumption. |
| Tolerances |
A tolerance for residues of ceftiofur in edible tissue of poultry and sheep is not required. Tolerances in swine for desfuroylceftiofur (marker residue) in edible swine tissues are 0.25 part per million in kidney (target tissue), 3 parts per million in liver, and 2 parts per million in muscle. Tolerances are established for residues of desfuroylceftiofur (marker residue) in edible cattle tissues at 0.4 parts per million in kidney (target tissue), 2 parts per million in the liver, 1 part per million in muscle, 100 parts per billion in milk. |